Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 50090-5107

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 50090-5107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of tramadol hydrochloride, showing the molecular arrangement of the active ingredient including aromatic rings and functional groups relevant to its pharmacological activity.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing Tramadol plasma concentration (ng/mL) over 24 hours after oral administration of two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and immediate-release Tramadol Hydrochloride Tablets 50 mg every 6 hours. The graph plots concentration against time in hours to show pharmacokinetic profiles of both formulations.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) in plasma over 24 hours for Tramadol Hydrochloride extended-release 200 mg tablets dosed once daily versus 50 mg tablets dosed every 6 hours. The x-axis represents time in hours (0-24) and the y-axis shows M1 concentration from 0 to 120 ng/mL. Concentration levels fluctuate with higher peaks seen in the 50 mg q6h dosing.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). The chart compares response rates among patients taking Tramadol Hydrochloride Extended-Release Tablets at doses of 100 mg, 200 mg, 300 mg, 400 mg, and a placebo. The x-axis represents response threshold from 0% to 100%, and the y-axis represents the percent of patients achieving response, ranging from 0% to 60%.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph from a Tramadol Hydrochloride Extended-Release Tablets study showing arthritis pain intensity response analysis. The x-axis represents response threshold as percent improvement from baseline and the y-axis shows the percent of patients achieving response. Two lines compare Tramadol Hydrochloride Extended-Release Tablets with placebo across various response thresholds, indicating higher patient response percentages for Tramadol Hydrochloride at all measured thresholds.*

FDA Label Image

Label Image (Lbl500905107)

TRAMADOL HYDROCHLORIDE 100 mg extended-release tablets, oral dosage form, labeler A-S Medication Solutions. The package contains 30 tablets. Storage instructions include keeping at 77 degrees Fahrenheit. The box includes NDC 50090-5107 and other identifying numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.